2Department of Cardiology, İstanbul Gaziosmanpaşa Training and Research Hospital, İstanbul, Türkiye
3Department of Cardiology, Karadeniz Ereğli State Hospital, Zonguldak, Türkiye
Abstract
Background: Catheter ablation is an effective treatment for patients with symptomatic atrial fibrillation (AF), and pulmonary vein isolation (PVI) is the cornerstone of AF ablation. Unlike thermal ablation, pulsed field ablation (PFA) uses nonthermal energy to irreversibly electroporate myocardial tissue without affecting adjacent structures such as the esophagus, phrenic nerve, and PV tissue. The aim of this study was to compare the efficacy and safety of the 2 most widely used single-shot ablation techniques worldwide: Cryoballoon (CB) and PFA. To date, this is the first PFA study to be published from Türkiye.
Methods: Consecutive AF patients who underwent PFA and CB-based PVI between July 2025 and February 2026 were enrolled. Cryoballoon PVI was performed using the 28-mm CB; PFA was performed using a 31 mm pentaspline catheter under fluoroscopic guidance.
Results: A total of 100 patients were included in the study (66% male, 64% with paroxysmal AF, mean age: 61.7 ± 11.8 years). There were 55 patients in the CB group and 45 patients in the PFA group. The skin-to-figure-of-8 time was significantly shorter in the
PFA group than in the CB group (30.00 [25.00-35.00] vs. 53.00 [47.00-55.00] minutes, P
< .001). No cerebrovascular events, groin complications, or pericardial effusions were observed in patients in either group. During the 6-month follow-up period, 4 (8.9%) cases of atrial arrhythmia were observed in the PFA group, compared to 7 (12.7%) in the CB
group (P = .406).
Conclusion: Both CB and PFA are safe and effective treatment methods for symptomatic patients diagnosed with AF. Compared to CB, acute procedure success rates and complications are similar in PFA, but procedure times are shorter.